Coleen Kathryn Cunningham, MD

Professor of Pediatrics
Chief, Division of Global Health, Pediatrics
Vice Chair of Research in the Department of Pediatrics
Research Professor of Global Health
Professor of Pathology
Campus mail:
Box 3352 Med Ctr, Durham, NC 27710
Phone:
(919) 684-6335
Email address:
coleen.cunningham@duke.edu
Dr. Cunningham is a pediatric infectious diseases physician who has focused her research on the prevention and treatment of HIV infection in children. She has also played important roles in evaluation of vaccines for other infectious diseases and recently has worked on Ebola virus treatment studies. She is currently working on studies of active and passive immunization to prevent HIV transmission in neonates born to HIV infected women.
Education and Training
- Fellow, Pediatric Infectious Diseases, Pediatrics, State University of New York Upstate Medical University, 1988 - 1991
- Residency, Pediatrics, State University of New York Upstate Medical University, 1985 - 1988
- M.D., State University of New York Upstate Medical University, 1985
Selected Grants and Awards
- Interdisciplinary Research Training Program in AIDS
- Nasopharyngeal Microbiome and Risk of Bacterial Pathogen Colonization in Infants
- Duke CTSA (TL1)
- Ryan White HIV/AIDS Program Part D Coordinated HIV Services and Access to Research for Women, Infants, Children, and Youth (WICY) in Central North Carolina
- A Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety,
and Antiviral Activity of the GS-9883/Emtricitabine/Tenofovir
Alafenamide (GS-9883/F/TAF) Fixed Dose Combination (FDC)
in HIV-1 Infected Virologically Suppressed Adolescents
and Children - Wake County Ryan White Part B
- LOC-IMPAACT - Protocol Chair support
- The impact of HIV infection or exposure on the upper respiratory microbiome of children in Botswana
- Integrating Mental Health into HIV Clinic to Improve Outcomes in Tanzanian Youth
- NICHD International and Domestic Pediatric and Maternal HIV Studies
- RSV2004-JNJ-64041575
- IMPAACT 2021 Protocol Chair
- LOC-IMPAACT - Protocol Chair support
- A Randomized, Double-blind, Placebo-controlled, 2-Part Study of Orally Administered ALS-008176 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Dosing and Multiple Ascending Dosing in Infants Hospitalize
- Duke Research Training Program for Pediatricians
- American Society of Tropical Medicine and Hygiene
- HIV Nurse Practitioner Training Program
- Center for Molecular & Cellular Studies of Ped Disease
- LOC - IMPAACT Leadership Group (IMPAACT 2013)
- LOC - IMPAACT Leadership Group (IMPAACT 2018)
- LOC-IMPAACT Leadership Group
- LOC - IMPAACT Leadership Group (IMPAACT 2012)
- GS-US-183-0160: Ph II/III Pharmacokinetics, Safety and Antiviral Activity of Elvitegravir
- NICHD International and Domestic Pediatric and Maternal HIV Studies
- Institutional Training Grant in Pediatric Infectious Disease
- UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
- LOC-IMPAACT Leadership Group
- HIV Pediatric Services
- 5UM1-AI069484-07 Supplement
- 05LOC-IMPAACT Leadership Group
- CORE / DUMC Pediatric Clinical Research Site (CRS) 1U01AI69484-01
- International Clinical Trials Unit
- HIV/AIDS Clinical Trials Unit (IMPAACT CTU)
- IMPAACT CTU
- Pilot Study for investigating micronucleated erythrocyte frequencies in infants
- Pediatrics AIDS Clincial Trials Unit